Literature DB >> 4108410

Immunofluorescence studies on sera of patients with breast carcinoma.

E S Priori, G Seman, L Dmochowski, H S Gallager, D E Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4108410     DOI： 10.1002/1097-0142(197112)28:6<1462::aid-cncr2820280620>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Immunofluorescence detection of casein in human mammary dysplastic and neoplastic tissues.

Authors:  G Bussolati; A Pich; V Alfani
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

2.  Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.

Authors:  R Schoorl; A B Riviere; A E Borne; T M Feltkamp-Vroom
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

3.  Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.

Authors:  C Alford; A C Hollinshead; R B Heberman
Journal:  Ann Surg       Date:  1973-07       Impact factor: 12.969

4.  The natural history of the antibody response to breast antigens.

Authors:  O R Boehm; B J Boehm; L J Humphrey
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

5.  [Association between tumor immunology, stromal reaction, and tumor endocarditis (author's transl)].

Authors:  P Stosiek
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

6.  Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.

Authors:  Y T Lee; K M Sheikh; F P Quismorio; G J Friou
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patients.

Authors:  M Higuchi; D S Robinson; R Cailleau; R F Irie; D L Morton
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

8.  Isolation from patients with breast cancer of antibodies specific for antigens associated with breast cancer and other malignant diseases.

Authors:  Y Gorsky; F Vanky; D Sulitzeanu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

9.  Autologous and homologous immunofluorescent antibody to established breast cancer cell lines.

Authors:  C Wiseman; R Cailleau; M Olivé; G R Blumenschein; J M Bowen
Journal:  In Vitro       Date:  1980-07

Review 10.  Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).

Authors:  Mariana Díaz-Zaragoza; Ricardo Hernández-Ávila; Rubí Viedma-Rodríguez; Diego Arenas-Aranda; Pedro Ostoa-Saloma
Journal:  Oncol Rep       Date:  2015-06-30       Impact factor: 3.906
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.